You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
GSK
since
auto-detected in 22 stories
2 days ago
New chief Luke Miels swoops on Canada’s 35Pharma in push to replenish pipeline and boost revenues
8 days ago
Peter Mandelson's lobbying firm goes into administration after clients flee in wake of Epstein revelations - as fellow friend of the paedophile Andrew Mountbatten-Windsor is arrested ○
Global Counsel was co-founded by Lord Mandelson and previously worked with a roster of clients including Palantir, GSK, Vodafone , TikTok and the Premier League .
23 days ago
GSK, take two: the bullish tone at the top is finally more convincing | Nils Pratley ⊕⊕
New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential
It’s a miracle. A mere 25 years after Glaxo Wellcome and SmithKline Beecham merg…
78 days ago
US is the best place for drugs companies to invest, says boss of London-based GSK ⊕⊕
found
a story from The Guardian ⚠️ › International
Emma Walmsley’s praise for US pharmaceutical market piles pressure on the UK government
Business live – live updates
The chief executive of GSK yesterday declared the US to be the best place for pharma…
79 days ago
UK pharma boss says US is the best country to invest in ⊕
In an interview with the BBC, Dame Emma Walmsley says she will not "shy away" from GSK's US expansion.
4 months ago
European stocks advance as pharma giants AstraZeneca and GSK notch gains ○
The U.K.'s FTSE 100 led gains on Monday.
GSK's Walmsley to step down early as insider Luke Miels named next CEO ○
found
GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday.
Pharma shake-up: Surprise change of CEO at GSK, as AstraZeneca announces New York stock market listing – business live ○
Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.
GSK’s Emma Walmsley to be replaced as chief executive
I…
5 months ago
ALEX BRUMMER: Donald Trump's big pharma win ○
found
a story from The Daily Mail 💩 › The Daily Mail
Britain's leading-edge big pharma companies AstraZeneca and GSK are pledging £59billion of investment in the US over the next five years. Spending in Blighty is on hold.
UK's GSK announces $30 billion U.S. pharma investment amid Trump state visit ○
British pharmaceutical giant GSK committed to investing at least $30 billion in U.S. research and developing and manufacturing over the next five years.